CN1173336A - External-use analgesic liquid for cancer - Google Patents
External-use analgesic liquid for cancer Download PDFInfo
- Publication number
- CN1173336A CN1173336A CN97118312A CN97118312A CN1173336A CN 1173336 A CN1173336 A CN 1173336A CN 97118312 A CN97118312 A CN 97118312A CN 97118312 A CN97118312 A CN 97118312A CN 1173336 A CN1173336 A CN 1173336A
- Authority
- CN
- China
- Prior art keywords
- external
- scolopendra
- cancer
- borneolum syntheticum
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
An exterior-used analgesic liquor for cancers is made up of borneol, minium and centipede through individual breaking, proportioning and mixing with spirit, and features distinct curative effect and convenient use.
Description
The present invention relates to a kind of pain relieving medicinal liquid that is used for cancer, is to be the Chinese patent medicine that feedstock production becomes with Chinese medicine specifically, the invention still further relates to the preparation method of this medicinal liquid.
Cancerous disease is as one of incurable disease, and it is seriously endangering people's health.Thereby, up to the present, also fail to work out effective treatment method of radical cure cancer.
The analgesic drug product that modern medicine had, as the dolantin injection, the person of how can only alleviating the light symptoms, and in, patient with advanced cancer, can not stop PD.Since a little less than the most body constitution of all kinds of patient with advanced cancer, poor to medicine injection absorbability, cause medicinal liquid by flowing out in the pin hole; Or take the Chinese medicine for oral administration method to patient's pain relieving, but for some patient swallow food difficulty be difficult to clothes down or clothes the vomiting phenomenon appears the back down, generally speaking, be difficult to reach analgesic effect.
The object of the present invention is to provide a kind of quiet analgesia that has, improve and alleviate the external-use analgesic liquid of cancer patient's misery.
Another object of the present invention also provides the preparation method of this external-use analgesic liquid.
Solution of the present invention is based on motherland's medical science and causes the pathogenetic understanding of pain for all kinds of cancers, principle with reference to modern pharmacological research, from medical treasure-house, filter out have analgesia, antidotal natural animal-plant medical herbs, improve to alleviate the effect that all kinds of pain among cancer patients pathological changes take place.
External-use analgesic liquid of the present invention is made (weight %) by following component
Borneolum Syntheticum 40-60% Plumbum preparatium 15-30% Scolopendra 20-35%
The optimum weight proportioning of external-use analgesic liquid of the present invention is
Borneolum Syntheticum 50% Plumbum preparatium 2 5% Scolopendras 25%
The production method of above-mentioned each component being made external-use analgesic liquid is:
1, gets Borneolum Syntheticum, Plumbum preparatium, Scolopendra pulverize separately earlier and be ground into 120 order fine powders;
2, with Borneolum Syntheticum, Plumbum preparatium, Scolopendra powder in described ratio uniform mixing;
3, select for use Chinese liquor to put into container, mixed raw material is modulated into the liquor medicine, the bottling sealing.
The clinical use result of externally-used pain-relieving medicinal liquid of the present invention shows to have following advantage:
1, to select natural animal-plant medicine for use be raw material in the present invention, utilizes the comprehensive function of the Chinese medicine of respectively distinguishing the flavor of to eliminate alleviating pain, without any side effects to human body, nontoxic.
2, the present invention need not inject or be oral, medicinal liquid need only be applied on the skin of pain spot to get final product, possibility of having avoided injecting drug use to bring the painful of patient or infect, suppurate, use operate very easy.
3, external-use analgesic liquid is neutral volatilised liq, and most of medicinal liquid rapid osmotic is absorbed in skin after the medication, the skin at the patient place of smearing is kept dry and cleans.
4, medicinal liquid adopts the liquor with high degree modulation, is convenient to seal long term storage, is difficult for losing efficacy.
For showing medicinal liquid of the present invention to eliminating the therapeutic effect of alleviating cancer pain, through 365 examples are suffered from osteocarcinoma, hepatocarcinoma, pulmonary carcinoma, intestinal cancer, breast carcinoma, gastric cancer, the age, the patient in 28-62 year carried out clinical practice, wherein invalid 14 examples; Effective 351 examples; Inefficiency is 3.8%; Effective percentage is 96.2%.
Using method: 5-20 gram/time, wipe every day 10 times, directly be applied in painful area.
Embodiment
Take by weighing raw material by following proportioning:
Borneolum Syntheticum 50 gram Plumbum preparatium 0.5 gram Scolopendra 0.5 gram
Production method is as follows:
Get Borneolum Syntheticum, Plumbum preparatium, Scolopendra pulverize separately earlier and be ground into 120 order fine powders, Borneolum Syntheticum, Plumbum preparatium, Scolopendra are pressed the formula proportion mix homogeneously after, select for use Chinese liquor 500 gram more than 50 ° to put into container and modulated several minutes, make the medicinal liquid agent, the bottling sealing.
Claims (4)
1, a kind of external-use analgesic liquid that is used for cancer is characterized in that it is the medicament of being made by following weight % proportion raw material
Borneolum Syntheticum 40-60% Plumbum preparatium 15-30% Scolopendra 20-35%
2, by the described external-use analgesic liquid of claim 1, wherein the weight proportion of each raw material is
Borneolum Syntheticum 50% Plumbum preparatium 25% Scolopendra 25%
3, by the described external-use analgesic liquid of claim 1, it is characterized in that described medicament is a liquor.
4, a kind of preparation method of using the external-use analgesic liquid of claim 3 is ground into 120 order fine powders with Borneolum Syntheticum, Plumbum preparatium, Scolopendra pulverize separately earlier, gets Borneolum Syntheticum, Plumbum preparatium, Scolopendra uniform mixing, puts into container with Chinese liquor 500 grams and mixes, and is modulated into the medicinal liquid agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97118312A CN1173336A (en) | 1997-09-12 | 1997-09-12 | External-use analgesic liquid for cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97118312A CN1173336A (en) | 1997-09-12 | 1997-09-12 | External-use analgesic liquid for cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1173336A true CN1173336A (en) | 1998-02-18 |
Family
ID=5174738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97118312A Pending CN1173336A (en) | 1997-09-12 | 1997-09-12 | External-use analgesic liquid for cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1173336A (en) |
-
1997
- 1997-09-12 CN CN97118312A patent/CN1173336A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1141929C (en) | Medicament and method of treating an organism with medicaments | |
| CN1583112A (en) | Capsules for nourishing kidney and strengthening yang | |
| CN1173336A (en) | External-use analgesic liquid for cancer | |
| CN1081104A (en) | Analgesic plaster for cancer pain and compound method thereof | |
| CN101085967A (en) | Rose flower wine | |
| CN1044561C (en) | Combined medicine for treatment of carcinomatosis and manufacturing method thereof | |
| CN115487268B (en) | Composition for promoting blood circulation and toxin metabolism and preparation method thereof | |
| CN1050759C (en) | Medicinal composite for hysteromyoma and preparing method | |
| CN100560118C (en) | A kind of Chinese medicine preparation for the treatment of recurrent oral ulceration | |
| CN101991829A (en) | Medicament for treating stomach illness | |
| CN1836668A (en) | External use traditional Chinese medicine powder for treating acute pancreatitis | |
| CN1031689C (en) | Medicine for treating lumbar vertebra hyperosteogeny diseases | |
| CN1087528A (en) | The Chinese prescription and the composite thereof of treatment hemorrhoid | |
| CN1264546C (en) | Prepared traditional medicine applied in tumor surgical operation, radiotheraphy and chemotherapy | |
| CN1098306A (en) | A kind of plaster sticking on umbilical region for the treatment of constipation and preparation method thereof | |
| CN1241616C (en) | Aloe and ant capsule | |
| CN1118262A (en) | Compounded composition for cancers | |
| CN109847007A (en) | Chinese medicine temperature-reducing paste and preparation method thereof | |
| CN106668826A (en) | Dietotherapy formula for treating arthritis | |
| CN1217189A (en) | Medicine for diminishing coagula and relieving pain-Sanjiexiaotongdan | |
| CN1137925A (en) | Health-care wine capable of nourishing Yin and invigorating Yang for adult and its preparation technology | |
| CN1060678C (en) | Medicine for treatment of wart and its compounding method | |
| CN1068499A (en) | Chinese medicine preparation---bonesetting spirit and compound method thereof | |
| CN1125129A (en) | Plaster for curing constipation | |
| CN116076719A (en) | Spleen-invigorating and lung-tonifying composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |